Wenjun Xiong

Wenjun Xiong


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2024 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
ZSzepang sun
zepang sun
TZTaojun Zhang
Taojun Zhang
MAM. Usman Ahmad
M. Usman Ahmad
ZZZixia Zhou
Zixia Zhou
LQLiang Qiu
Liang Qiu
YJYuming Jiang
Yuming Jiang
BACKGROUND: The tumor immune microenvironment can provide prognostic and therapeutic information. We aimed to develop noninvasive imaging biomarkers from computed tomography (CT) for comprehensive evaluation of immune context and investigate their associations with prognosis and immunotherapy response in gastric cancer (GC). METHODS: This study involved 2,600 patients with GC from 9 independent cohorts. We developed and validated 2 CT imaging biomarkers (lymphoid radiomics score [LRS] and myeloid radiomics score [MRS]) for evaluating the IHC-derived lymphoid and myeloid immune context respectively, and integrated them into a combined imaging biomarker [LRS/MRS: low(−) or high(+)] with 4 radiomics immune subtypes: 1 (−/−), 2 (+/−), 3 (−/+), and 4 (+/+). We further evaluated the imaging biomarkers’ predictive values on prognosis and immunotherapy response. RESULTS: The developed imaging biomarkers (LRS and MRS) had a high accuracy in predicting lymphoid (AUC range: 0.765–0.773) and myeloid (AUC range: 0.736–0.750) immune context. Further, similar to the IHC-derived immune context, 2 imaging biomarkers (HR range: 0.240–0.761 for LRS; 1.301–4.012 for MRS) and the combined biomarker were independent predictors for disease-free and overall survival in the training and all validation cohorts (all P < 0.05). Additionally, patients with high LRS or low MRS may benefit more from immunotherapy ( P < 0.001). Further, a highly heterogeneous outcome on objective response rate was observed in 4 imaging subtypes: 1 (−/−) with 27.3%, 2 (+/−) with 53.3%, 3 (−/+) with 10.2%, and 4 (+/+) with 30.0% ( P < 0.0001). CONCLUSION: The noninvasive imaging biomarkers could accurately evaluate the immune context and provide information regarding prognosis and immunotherapy for GC.

23 July 2015 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
WWwei wang
wei wang
ZLZhiwei Liu
Zhiwei Liu
WXWenjun Xiong
Wenjun Xiong
YZYansheng Zheng
Yansheng Zheng
LLLijie Luo
Lijie Luo
JWJin Wan
Jin Wan

21 October 2025 in Phytomedicine
Verified
Journal Article
Closed access
YWYu Wei
Yu Wei
ZJZhangyu Jiang
Zhangyu Jiang
CSChanglin Song
Changlin Song
YQYuanyuan Qiao
Yuanyuan Qiao
XWXianzhe Wang
Xianzhe Wang
WWwei wang
wei wang

12 March 2025 in Hernia
Verified
Journal Article
Closed access
PDF file
YZYansheng Zheng
Yansheng Zheng
YXYuling Xue
Yuling Xue
KLKeling Li
Keling Li
ZZZhe Zhang
Zhe Zhang
ZWZhenhui Wan
Zhenhui Wan
JLJin Li
Jin Li

1 January 2020 in Technology in Cancer Research & Treatment
Verified
Journal Article
Open access
PDF file
HHHai-Peng Huang
Hai-Peng Huang
WXWenjun Xiong
Wenjun Xiong
YPYao-Hui Peng
Yao-Hui Peng
YZYan-Sheng Zheng
Yan-Sheng Zheng
LLLi-Jie Luo
Li-Jie Luo
WWwei wang
wei wang
Background: Traditional laparoscopic No.12a lymph node dissection in radical gastrectomy for gastric cancer may damage the peripheral blood vessels, and is not conducive to the full exposure of the portal vein and the root ligation of the left gastric vein. We recommend a new surgical procedure, the portal vein approach, to avoid these problems. Methods: 25 patients with advanced gastric cancer underwent radical laparoscopic gastrectomy and No.12a lymph node were dissected by portal vein approach, including 7 cases with total gastrectomy, 18 cases with distal gastric resection, 14 males and 11 females. Operative time, intraoperative blood loss, time to first flatus, postoperative hospital stay, number of total lymph node dissection and No.12a lymph node dissection, No.12a lymph node metastasis rate and postoperative complications were statistically observed. Results: All the patients were operated successfully and No.12a lymph node were cleaned by portal vein approach. A total of 683 lymph nodes were dissected, with the average number of lymph nodes dissection and positive lymph nodes were (27.3 ± 12.7) and (3.8 ± 5.6) respectively. The average number of No.12a lymph node dissection was (2.4 ± 1.95) and the metastasis rate of No.12a lymph node was 16% (4/25). The average operation time of radical laparoscopic distal and total gastrectomy were (239.2 ± 51.4) min and (295.1 ± 27.7) min respectively. The mean intraoperative blood loss was (134.0 ± 65.7) ml, and postoperative first anal exhaust time was (2.24 ± 0.86) d. The mean time to fluid intake was (4.2 ± 1.7) d, and postoperative hospitalization time was (9.6 ± 5.0) d. Without portal vein injure, anastomotic leakage, gastrointestinal bleeding, intestinal obstruction and other complications were observed in all patient. Conclusion: Our results show that the laparoscopic No.12a lymph node dissection by portal vein approach for gastric cancer is safe, feasible and has certain clinical application value.

1 November 2015
Verified
Journal Article
Closed access
LZLiaonan Zou
Liaonan Zou
WXWenjun Xiong
Wenjun Xiong
HLHongming Li
Hongming Li
YHYaobin He
Yaobin He
DDDechang Diao
Dechang Diao
JWJin Wan
Jin Wan